代表性科研項目:
1. 2022年青海省科技廳科技援青合作專項(2022-QY-201),基於酶催化新策略合成阿苯達唑-膽酸前藥提高肝包蟲病治療效果,2022/01-2024/12,在研、主持,70萬
2. 2021年國家自然基金(82060644),微觀結構對藥物結晶固體分散體關鍵藥劑學參數的影響機制研究,2021/01-2024/12,在研、主持,34萬
3. 2020 年青海大學青年基金項目團隊項目(2020-QYY-1),基於物理藥劑學原理提高阿苯達唑-膽酸衍生物生物利用度和包蟲病效果的研究,2020/12-2023/12,在研、主持,10萬
4. 省部共建三江源生態與高原農牧業國家重點實驗室自主課題(2019 -ZZ-01),砂生槐子總生物鹼的高效提取方法及其肝靶向製劑的研究,2019/07-2021/07, 在研、主持,10萬
5. 青海省科技廳重大專項(2016-SF-A5)—子課題:提高口服生物利用度的新型阿苯達唑固體製劑研究、2016/12-2019/12,結題、子課題主持人,25萬
人才計畫項目情況:
1. 2020年入選青海省“高端創新人才千人計畫”拔尖人才。
2. 2022年中科院“西部之光”人才培養計畫
代表性論文:
1. Chunhui Hu,Xuehui Gan,Qiangqiang Jia,Pan Gao,Tao Du,Fabin Zhang. Optimization of Supercritical-CO2Extraction and Pharmacokinetics in SD rats of Alkaloids Form Sophora moorcroftiana seed. Scientific Reports. (2022) : (IF=4.379)
2. Hu Chunhui, Zhang Fabin, FanHaining. Improvement of the Bioavailability andAnti-Hepatic Alveolar Echinococcosis by Albendazole-Isethionate/HypromelloseAcetate Succinate (HPMC-AS) Complex. Antimicrobial Agents and Chemotherapy.65, 7 (2021) : (IF=5.191)
3. Hu Chunhui, Zhang Fabin, FanHaining. Evaluation of Drug Dissolution Rate in Co-amorphous andCo-crystal Binary Drug Delivery Systems by Thermodynamic and Kinetic Methods.AAPS pharmscitech. 22, 21 (2021) (IF=3.246) 中科院3區
4. Hu Chunhui, Liu Zhengsheng, Liu Chengyu,Zhang Yaogang, Fan Haining, Qian, Feng. Improvement of AntialveolarEchinococcosis Efficacy of Albendazole by a Novel Nanocrystalline Formulationwith Enhanced Oral Bioavailability. ACS infectious diseases. 2020, 6, 5,802–810 (IF=5.084)
5. Hu Chunhui,Liu Zhengsheng, Liu Chengyu, Li Jianhua, Wang Zhixin,Xu Liuting, Chen Cen, Fan Haining, Qian Feng. Enhanced Oral Bioavailability andAnti-Echinococcosis Efficacy of Albendazole Achieved by Optimizing the"Spring" and "Parachute". Molecular pharmaceutics. 2019, 16, 12, 4978-4986 (IF=4.939)